Christopher Peetz
Director; Director, CHIEF EXECUTIVE OFFICER · 11 filings · Latest: Oct 6, 2026
Arcutis Biotherapeutics, Inc.
Mirum Pharmaceuticals, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
MIRM | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Oct 6, 2026 | Option Exercise | $17.31 | 12,197 | $211.2K | 206,637 | |
MIRM | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Sep 1, 2026 | Sale | $98.68 | 30,000 | $3.0M | 194,440 | |
MIRM | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Sep 1, 2026 | Option Exercise | $2.94 | 30,000 | $88.1K | 224,440 | |
MIRM | CHRISTOPHER PEETZ | — | Sep 1, 2026 | Proposed Sale | $98.68 | 30,000 | $3.0M | — | |
MIRM | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Aug 10, 2026 | Sale | $98.92 | 20,000 | $2.0M | 194,309 | |
MIRM | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Aug 10, 2026 | Option Exercise | $2.94 | 20,000 | $58.7K | 214,309 | |
MIRM | CHRISTOPHER PEETZ | — | Aug 10, 2026 | Proposed Sale | $98.92 | 20,000 | $2.0M | — | |
MIRM | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Jul 6, 2026 | Sale | $122.27 | 20,000 | $2.4M | 194,309 | |
MIRM | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Jul 6, 2026 | Option Exercise | $2.94 | 20,000 | $58.7K | 214,309 | |
MIRM | CHRISTOPHER PEETZ | — | Jul 6, 2026 | Proposed Sale | $122.27 | 20,000 | $2.4M | — | |
MIRM | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Jun 1, 2026 | Sale | $95.84 | 30,000 | $2.9M | 194,309 | |
MIRM | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Jun 1, 2026 | Option Exercise | $2.94 | 30,000 | $88.1K | 224,309 | |
MIRM | CHRISTOPHER PEETZ | — | Jun 1, 2026 | Proposed Sale | $95.84 | 30,000 | $2.9M | — | |
MIRM | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Mar 16, 2026 | Sale | $91.98 | 40,985 | $3.8M | 194,309 | |
MIRM | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Mar 15, 2026 | Option Exercise | — | 75,000 | — | 235,294 | |
MIRM | Christopher Peetz | — | Mar 16, 2026 | Proposed Sale | $92.64 | 40,985 | $3.8M | — | |
MIRM | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Feb 2, 2026 | Sale | $103.30 | 9,108 | $940.9K | 160,294 | |
MIRM | Christopher Peetz | — | Feb 2, 2026 | Proposed Sale | $103.80 | 9,108 | $945.4K | — | |
MIRM | Christopher Peetz | — | Jan 26, 2026 | Proposed Sale | $96.92 | 6,831 | $662.1K | — | |
MIRM | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Jan 26, 2026 | Sale | $96.19 | 6,831 | $657.1K | 169,402 |
Page 1 of 2
Next →